Inhibiting the SARS-CoV-2 (COVID-19) virus while also tackling the associated inflammation may be possible with a nano-bait strategy based on exosome-sheathed polydopamine nanoparticles for this therapeutic application.
The development of polymeric nanocomposites for various nanotechnology and biomedical science applications has recently gained interest for its potential use within prosthetics.